Literature DB >> 20860050

Nanotechnology and HIV: potential applications for treatment and prevention.

Peter S Kim1, Sarah W Read.   

Abstract

HIV/AIDS is a global pandemic and is the leading infectious cause of death among adults. Although antiretroviral (ARV) therapy has dramatically improved the quality of life and increased the life expectancy of those infected with HIV, life-long suppressive treatment is required and a cure for HIV infection remains elusive; frequency of dosing and drug toxicity as well as the development of viral resistance pose additional limitations. Furthermore, preventative measures such as a vaccine or microbicide are urgently needed to curb the rate of new infections. The capabilities inherent to nanotechnology hold much potential for impact in the field of HIV treatment and prevention. This article reviews the potential for the multidisciplinary field of nanotechnology to advance the fields of HIV treatment and prevention.
© 2010 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860050     DOI: 10.1002/wnan.118

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  11 in total

Review 1.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

Review 2.  Shedding light on nanomedicine.

Authors:  Rong Tong; Daniel S Kohane
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-08-09

Review 3.  Anti-HIV-1 nanotherapeutics: promises and challenges for the future.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Wing-Cheung Law; Jessica L Reynolds; Bindukumar B Nair; Donald E Sykes; Ken-Tye Yong; Indrajit Roy; Paras N Prasad; Stanley A Schwartz
Journal:  Int J Nanomedicine       Date:  2012-10-05

Review 4.  Nanotechnology and the treatment of HIV infection.

Authors:  Raveen Parboosing; Glenn E M Maguire; Patrick Govender; Hendrik G Kruger
Journal:  Viruses       Date:  2012-04-10       Impact factor: 5.048

Review 5.  Achieving a cure for HIV infection: do we have reasons to be optimistic?

Authors:  Valentin Le Douce; Andrea Janossy; Houda Hallay; Sultan Ali; Raphael Riclet; Olivier Rohr; Christian Schwartz
Journal:  J Antimicrob Chemother       Date:  2012-02-01       Impact factor: 5.790

Review 6.  Macrophage derived cystatin B/cathepsin B in HIV replication and neuropathogenesis.

Authors:  Linda E Rivera; Krystal Colon; Yisel M Cantres-Rosario; Frances M Zenon; Loyda M Melendez
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

Review 7.  Harnessing nanostructured systems for improved treatment and prevention of HIV disease.

Authors:  Maya Monroe; Charles Flexner; Honggang Cui
Journal:  Bioeng Transl Med       Date:  2018-07-27

Review 8.  Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs.

Authors:  Leila Fotooh Abadi; Fouad Damiri; Mehrukh Zehravi; Rohit Joshi; Rohan Pai; Mohammed Berrada; Ehab El Sayed Massoud; Md Habibur Rahman; Satish Rojekar; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-07-29       Impact factor: 4.967

Review 9.  Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: The role of stereology.

Authors:  Edwin Coleridge S Naidu; Samuel Oluwaseun Olojede; Sodiq Kolawole Lawal; Carmen Olivia Rennie; Onyemaechi Okpara Azu
Journal:  Pharmacol Res Perspect       Date:  2021-05

10.  Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.

Authors:  Thanyanan Chaowanachan; Emily Krogstad; Cameron Ball; Kim A Woodrow
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.